COGT vs GPC · $5.75B cap vs P/E 21, rev $12.80B
Cogent Biosciences Inc (COGT) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
Genuine Parts Co (GPC) is a auto parts company listed on US.
COGT does not have a complete income-statement cache yet.
Latest reported GPC revenue for 2026-06-30 was $12.80B. Net income was $416.1M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
COGT currently screens at market cap $5.75B. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the COGT and GPC stock pages for the full models.
Not investment advice.